Understanding the utility of plasmas for medical applications

November 24, 2020

WASHINGTON, November 24, 2020 -- Plasma medicine is an emerging field, as plasmas show promise for use in a wide range of therapies from wound healing to cancer treatment. Plasma jets are the main plasma sources typically used in plasma-surface applications. Before applications can progress, however, a better understanding of how plasma jets modify the surfaces of biological tissue is required.

To help with this understanding, researchers from the Russian Academy of Sciences conducted computer simulations of the interaction between an atmospheric pressure plasma jet with a surface that has properties similar to blood serum. They present their analysis in the Journal of Applied Physics, from AIP Publishing.

"While using the plasma jets for the purpose of plasma medicine, it is important to know that the presence or absence of the treated surface in vicinity of a jet significantly influences jet parameters," said Natalia Babaeva, one of the authors. "For example, the wounds with blood serum can have different properties. These properties can also vary during the plasma treatment."

Depending on the characteristics of the tissue being treated, the plasma jet can behave in a number of different ways. The ionization waves produced by plasma jets may reflect back and forth, or they can spread over the tissue as surface discharge.

For the type of plasma Babaeva and her team studied, they found that the biomaterial-like surface can lead to multiple reflections of the plasma jet, and with each passage, the number of electrons and radicals -- a type of very reactive molecule -- increases. Specifically, the radicals identified are oxygen, hydroxide, hydrogen peroxide, ozone, and nitric oxide, also known as reactive oxygen species and reactive nitrogen species.

"Reactive oxygen species and reactive nitrogen species are important for the actions of antimicrobial drugs, cancer, and wound healing therapies," Babaeva said, adding that they both play an active role in the immune systems of animals and plants.

Quantifying these radicals and understanding the direction and magnitude of their flow is important for optimizing plasmas for use in biomedical applications, where the ability to control their behavior to some degree is crucial. The team's simulations provide the means to predict this behavior.

"This prediction is very important, as it determines the plasma treatment potential," Babaeva said. "Our research adds some knowledge on the particular behavior of the jet in the presence of highly conductive surfaces."
-end-
The article, "Reactive fluxes delivered by plasma jets to conductive dielectric surfaces during multiple reflections of ionization waves," is authored by Natalia Yu. Babaeva and George V. Naidis. The article will appear in the Journal of Applied Physics on Nov. 24, 2020 (DOI: 10.1063/5.0019350). After that date, it can be accessed at https://aip.scitation.org/doi/10.1063/5.0019350.

ABOUT THE JOURNAL

The Journal of Applied Physics is an influential international journal publishing significant new experimental and theoretical results in all areas of applied physics. See https://aip.scitation.org/journal/jap.

American Institute of Physics

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.